Multipotent mesenchymal stromal cells (MSCs) are found in a variety of adult tissues including human dermis. These MSCs are morphologically similar to bone marrow-derived MSCs, but are of unclear phenotype. To shed light on the characteristics of human dermal MSCs, this study was designed to identify and isolate dermal MSCs by a specific marker expression profile, and subsequently rate their mesenchymal differentiation potential. Immunohistochemical staining showed that MSC markers CD73/CD90/CD105, as well as CD271 and SSEA-4, are expressed on dermal cells in situ. Flow cytometric analysis revealed a phenotype similar to bone marrow-derived MSCs. Human dermal cells isolated by plastic adherence had a lower differentiation capacity as compared with bone marrow-derived MSCs. To distinguish dermal MSCs from differentiated fibroblasts, we immunoselected CD271 þ and SSEA-4 þ cells from adherent dermal cells and investigated their mesenchymal differentiation capacity. This revealed that cells with increased adipogenic, osteogenic, and chondrogenic potential were enriched in the dermal CD271 þ population. The differentiation potential of dermal SSEA-4 þ cells, in contrast, appeared to be limited to adipogenesis. These results indicate that specific cell populations with variable mesenchymal differentiation potential can be isolated from human dermis. Moreover, we identified three different subsets of dermal mesenchymal progenitor cells.
INTRODUCTION
The major obstacle for the identification of multipotent mesenchymal stromal cells (MSC) is their morphological and phenotypical similarity to fibroblasts. Even 40 years after their first description, no definite cell surface marker is available that reliably identifies MSCs and enables their isolation (Friedenstein et al., 1966) . Rather, a variety of markers are used for the identification of MSCs. Recently, the multitude of cell surface markers used in various studies has been limited to a marker panel representing, in addition to plastic adherence and differentiation capacity, the minimal criteria for the identification of MSCs (Dominici et al., 2006) . These markers, however, do not discriminate between MSCs and fibroblasts (Haniffa et al., 2009 ) and partially overlap with other cell lineages. Nevertheless, the prevailing method for the isolation of MSCs irrespective of the original tissue is plastic adherence, which in turn leads to the selection of a very heterogeneous starting population (Ho et al., 2008) . Therefore, a number of approaches have been undertaken to identify cell surface markers that hold promise for a specific isolation of MSCs from various tissues that include CD49a (Deschaseaux et al., 2003) , CD105 (Conconi et al., 2006) , CD271 (Quirici et al., 2002; Bü hring et al., 2007) , GD2 (Martinez et al., 2007) , SSEA-4 (Gang et al., 2007) , and STRO-1 (Simmons and Torok-Storb, 1991) . Apart from bone marrow, MSCs have been isolated from a variety of other tissues, such as umbilical cord blood (Erices et al., 2000; Mareschi et al., 2001) , adipose tissue (Miyazaki et al., 2005; Gimble et al., 2007) , placenta (Fukuchi et al., 2004; Miao et al., 2006; Battula et al., 2007) , synovial fluid (Jones et al., 2004) , fibrous and adipose synovium (Mochizuki et al., 2006) , pancreas (Seeberger et al., 2006; Gallo et al., 2007) , and dermis (Yates et al., 2001; Young et al., 2001; Bartsch et al., 2005; Chen et al., 2007; Lysy et al., 2007) .
The main focus of cutaneous stem cell research is on epidermal stem cells and stem cells associated with the hair follicle. However, various studies proved the presence of mesenchymal progenitors also in the dermis. Skin-derived precursors with the capacity of neural and mesodermal differentiation were obtained from nonadherent dermal cells (Yates et al., 2001; Young et al., 2001; Bartsch et al., 2005; Toma et al., 2005; Chen et al., 2007; Lysy et al., 2007) . Other studies, in contrast, identified mesenchymal progenitor cells within the fraction of plastic-adherent dermal cells (Bartsch et al., 2005; Chen et al., 2007; Lysy et al., 2007; Lorenz et al., 2008) . Among other cell types, adherent dermal cells include fibroblasts, which are the prevailing cell type in the dermis and are of a yet not fully understood physiological heterogeneity (Sorrell et al., 2007) . In addition, adherent dermal cells contain subsets that are capable of differentiating into osteoblasts, adipocytes, chondrocytes (Lorenz et al., 2008) , and myocytes (Bartsch et al., 2005) . Even ectodermal and endodermal potential has been assigned to these cells (Chen et al., 2007; Lysy et al., 2007) . When using cell surface markers commonly used for the characterization of MSCs, the phenotype of dermal fibroblasts was largely similar to that of bone marrow-derived MSCs (Ishii et al., 2005; Wagner et al., 2005; Chen et al., 2007) . There are, however, approaches to identify phenotypically distinct progenitor cells from overall fibroblasts. Chen et al. (2007) identified a nestin À vimentin þ multipotent dermal fibroblast and thereby provide evidence for the possible isolation of progenitor subsets from dermal adherent cells.
The goal of our study was to characterize MSCs in human dermis and isolate progenitor cell subsets based on a specific phenotype for further investigation.
RESULTS

MSC markers are expressed on various dermal cell types
The presence of mesenchymal stem/progenitor cells in human dermis has been reported previously (Toma et al., 2001; Yates et al., 2001; Young et al., 2001; Bartsch et al., 2005; Chen et al., 2007; Lysy et al., 2007) . As their phenotype is still poorly characterized, we analyzed the expression of MSC markers in human dermis. In situ analysis of skin cryosections by immunohistochemical staining revealed that MSC markers (CD73, CD90, CD105, CD271, SSEA-4) are expressed on different dermal cell types (Figure 1a , upper panel). CD73, CD90, and CD105 show similar single-cell, vascular and perivascular expression patterns (Figure 1a , inset, lower panel). It is noteworthy that CD90 is also faintly expressed on some basal keratinocytes, thus confirming previous results (Nakamura et al., 2006) . In contrast, CD271 is present on cutaneous nerve fibers, Schwann cells, dermal single cells, and, faintly, on clusters of basal keratinocytes as reported (Figure 1a , inset, lower panel; Liang et al., 1999; Nakamura et al., 2007) . The dermal expression pattern of SSEA-4 is almost analogous to CD271. As SSEA-4 expression has been demonstrated on neural cells (Dodd and Jessell, 1986; Holford et al., 1994; Barraud et al., 2007) , we conclude that SSEA-4 is also expressed on neural structures in human dermis and, to a lesser extent, on dermal single cells. These observations confirm the shared expression of markers used for the identification of MSCs by a variety of cell types (Kolf et al., 2007) . For a more detailed analysis of dermal cell populations expressing MSC markers, we double-and triple-stained dermal single-cell suspensions and analyzed them by flow cytometry. The marker combinations were selected to define cell types typically found in human dermis, such as endothelial cells (CD31 þ , CD34 þ ) and leukocytes (CD45 þ ). As a marker for ''contaminating'' keratinocytes, we used CD318 (Brown et al., 2004) . Apart from CD73 þ , CD90 þ , and CD105 þ cells co-expressing CD31 and CD34 or CD45, we identified CD73 þ , CD90 þ , and CD105 þ cells lacking endothelial and leukocyte 2 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 markers, thus rendering these cells potential mesenchymal progenitor cells ( Figure 1b ; Dominici et al., 2006) . CD271 and SSEA-4, in contrast, were only negligibly expressed on endothelial cells in human dermis, but we detected small populations of CD271 þ CD45 þ cells and SSEA-4 þ CD45 þ cells. Corroborating our immunohistochemistry staining, we found expression of CD318 only on a small population of CD271 þ and CD90 þ cells, which are most probably keratinocyte stem/progenitor cells (Figure 1b ; Liang et al., 1999) . CD318 þ cells occur in variable numbers in dermal single-cell suspensions and represent epithelial cells derived from skin appendages and epidermal cells (Brown et al., 2004) as contaminants of the incomplete removal of the epidermis during the skin preparation procedure.
Adherent dermal cells have MSC characteristics
To test whether adherent dermal cells harbor mesenchymal progenitors, they were subjected to mesenchymal differentiation assays. Similar to previous observations (Yates et al., 2001; Young et al., 2001; Bartsch et al., 2005; Chen et al., 2007; Lysy et al., 2007; Lorenz et al., 2008) , we found that human dermis contains cells capable of differentiating into osteoblasts and adipocytes (Figure 2a ), whereas we could never observe chondrogenic differentiation of adherent dermal cells without further enrichment (data not shown). Adipogenic and osteogenic differentiation was confirmed by molecular analysis in comparison with negative controls using peroxisome proliferator-activated receptor-g-2 or alkaline phosphatase (AP) and osteocalcin, respectively (Supplementary Figure S1 online). Assuming that phenotypic analysis of adherent dermal cells is informative regarding the nature of cells capable of mesenchymal differentiation, they were subjected to analysis by flow cytometry with a selection of MSC markers. We found that dermis-derived cells express all mesenchymal markers such as CD10, CD13, CD26, CD29, CD44, CD71, CD73, CD90, CD105, CD146, and to a lesser extent CD106, CD271, STRO-1, and SSEA-4, thus exhibiting the phenotype reported for mesenchymal progenitor cells (Figure 2b ; Minguell et al., 2001; Dominici et al., 2006; Chamberlain et al., 2007) . We next compared the phenotype of adherent dermal cells and bone marrowderived cells, both cultured under the same conditions ( Figure 2c ), and thereby confirmed the intriguing phenotypic similarity of dermis-and bone marrow-derived cells. The expression of CD29, CD73, CD90, CD105, CD106, and SSEA-4 was significantly higher on bone marrow-derived cells (Figure 2c ). Dermis-and bone marrow-derived cells showed either no expression or only negligible expression of endothelial cell and hematopoietic stem cell markers (CD34, CD133), co-stimulatory molecules for T-cell activation (CD80, CD86), leukocyte maturation markers (CD83), and HLA-DR. Only the leukocyte common antigen CD45 was expressed on significantly more dermis-derived cells. Virtually all cells expressed HLA-ABC, whereas HLA-DR expression was hardly detectable on either cell type. Half of the dermis-and bone marrow-derived cells were CD318 þ (Figure 2c ). The fact that CD318 can be detected on certain subsets of mesenchymal stromal cells has been reported previously (Battula et al., 2008) . Interestingly, under adipogenic culture conditions, virtually every adherent bone marrow-derived cell differentiated, whereas only a proportion of adherent dermal cells formed adipocytes ( Figure 2d ).
CD73 þ cells show a significantly higher adipogenic differentiation capacity than CD90 þ cells Multicolor flow cytometry analysis of the expression of MSC markers on adherent dermal cells revealed that CD73 and CD105 are co-expressed. Co-expression of CD73 and CD105 was also observed in freshly isolated dermal cells (Supplementary Figure S2 online). CD90, in contrast, was not expressed on all adherent dermal cells, as a minor population of the CD73 þ cells is CD90 À (Figure 3a ). CD271 þ cells were CD73 þ and CD105 þ , whereas the majority of CD271 þ cells were CD90 À (Figure 3b , upper panel). Visualization of CD271 þ cells clearly showed their localization within the CD73 þ CD105 þ cells, whereas only a small subset of CD73 þ CD90 þ cells expressed CD271 (Figure 3b , lower panel). This difference between CD73 þ and CD90 þ dermal cells with respect to expression of the MSC marker CD271 might reflect different stem/progenitor cell properties. We therefore directly compared the adipogenic differentiation capacity of CD73 þ and CD90 þ cells (purity 485%) isolated from freshly prepared dermal cell suspensions of the same skin sample to exclude donor-dependent variability and included the respective unfractionated dermal single-cell suspensions. We found that the differentiation capacity of CD73 þ cells was significantly higher when compared with CD90 þ cells (896.4±309.1 vs. 323.9±132.8 adipocytes per well; Po0.006; n ¼ 5) and total dermal cells (520.4±139.4 adipocytes per well; Po0.02; Figure 3c , left panel). Interestingly, the differentiation capacity of CD90 þ cells is even significantly lower when compared with total dermal cells (Po0.04). For control purposes, we also investigated the differentiation potential of the CD73 À (260.4 ± 380.2 adipocytes per well) and CD90 À (594 ± 554.9 adipocytes per well) fractions of the respective experiments (Figure 3c , right panel). Negative fractions diverged from the respective positive fractions regarding adipogenic differentiation. However, the fact that the negative fractions still contained considerable numbers of positive cells (8-22%) potentially influences the results. We showed that the MSC markers CD271 and SSEA-4 are only expressed on a small subset of adherent dermal cells (Figure 2b , inset) implying a progenitor cell nature. To test this hypothesis, the adherent dermal cell fraction was magnetic-activated cell sorted for CD271 þ or SSEA-4 þ cells, which, together with the respective negative and total dermal cell fraction of the same skin sample, were subjected to differentiation assays (Figure 4c and b ). We found that CD271 þ cells possess a 3-or 2-fold higher adipogenic differentiation capacity than CD271 À (P ¼ 0.003, n ¼ 5) or total dermal cells (P ¼ 0.003; Figure 4c and e). As expected, the number of adipocytes in the CD271 À fractions was 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 Stromal Cell Subsets in Human Dermis significantly lower than in total adherent dermal cells (P ¼ 0.011). Similar to CD271 þ cells, SSEA-4 þ cells exhibited a significantly higher adipogenic differentiation potential than the SSEA-4 À fractions (P ¼ 0.049) and total dermal cells (Figure 4d and f). To evaluate the MSC nature of dermal subpopulations, we also investigated the osteogenic and chondrogenic differentiation potential of dermal CD271 þ and SSEA-4 þ cells.
The osteogenic potential was assessed qualitatively by Alizarin red staining (Figure 5a and b) , which revealed strong staining of the CD271 þ fraction in comparison with the negative and total dermal cell fraction. Comparison of SSEA-4 þ cells with the respective cell fractions, however, did not show any apparent differences with regard to Alizarin red staining. Quantitatively we determined osteogenic differentiation by measurement of AP levels (Figure 5c and d) .
Significantly higher AP levels in the CD271 þ fraction than in the respective negative (P ¼ 0.0278; n ¼ 5) and total dermal cell fractions (P ¼ 0.0129) reflect the high osteogenic potential of CD271 þ cells (Figure 5c ). In contrast, we could not detect any differences in the AP levels when comparing SSEA-4 þ , SSEA-4 À , and total adherent dermal cells ( Figure  5d ). Similar to osteogenic differentiation, only CD271 þ dermal cells were able to give rise to typical chondrocytes (Figure 5e , arrow), whereas they have not been found in the 10 0 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 CD73 other investigated cell fractions including SSEA-4 þ cells (Figure 5e ). All cell fractions formed a typical chondrogenic micromass. These differences in the osteogenic and chondrogenic potential between CD271 þ and SSEA-4 þ dermal cells provide evidence that these populations represent distinct dermal progenitor cells. Analyses of adherent dermal cells confirmed that dermal CD271 þ and SSEA-4 þ cells mutually exclude each other and seem to represent two separate populations (Figure 5g ). Our results clearly show that cell populations that possess divergent mesenchymal differentiation potential can be isolated from fresh dermal cell suspensions, as well as from dermal cells preselected by plastic adherence. Among the cell populations investigated in our study, however, only CD271 þ cells show significantly elevated differentiation potential in comparison with CD271 À , as well as total dermal cells in all differentiation assays performed.
DISCUSSION
We have shown for the first time that distinct populations of cells expressing MSC markers can be isolated from freshly separated and adherent cultured dermal cells, which to our knowledge is previously unreported. On the basis of comprehensive analysis by immunohistochemistry and flow cytometry, we isolated three cell populations that exhibit either significantly elevated mesenchymal differentiation potential in all three differentiation assays performed compared with the negative fractions and total dermal cells (CD271) or show elevated, however, in some respects, restricted differentiation potential (CD73 and SSEA-4).
MSCs have been isolated from a wide range of tissues (Erices et al., 2000; Mareschi et al., 2001; Yates et al., 2001; Young et al., 2001; Fukuchi et al., 2004; Jones et al., 2004; Bartsch et al., 2005; Miyazaki et al., 2005; Miao et al., 2006; Mochizuki et al., 2006; Seeberger et al., 2006; Battula et al., 2007 Battula et al., , 2008 Chen et al., 2007; Gallo et al., 2007; Gimble et al., 2007; Lysy et al., 2007) . Assessment of the expression of MSC markers in widely hair follicle-free skin revealed that antigens frequently used for the characterization of MSCs in various tissues are also expressed in human dermis, and that their expression evidently overlaps with other lineages such as endothelial cells, leukocytes, keratinocytes, and neural structures. These findings emphasize the difficulty of identifying MSCs in freshly prepared tissues and imply the necessity of preselecting the dermal stromal fraction by plastic adherence. There exist concerns that the typical properties of MSCs are culture phenomena, most importantly because only few studies use noncultured MSCs as reviewed by Javazon et al. (2004) . Our experiments investigating the differentiation capacity of CD73 þ cells isolated from freshly prepared dermal single-cell suspensions indicate that this cell fraction is enriched for MSCs in comparison with CD90 þ cells. This demonstrates that cells with MSC characteristics can directly be isolated from the dermis using specific antibodies without preselection by plastic adherence. Similarly, CD105 þ cells were isolated from noncultured bone marrow aspirates, showing that CD105 þ cells form significantly higher numbers of colony-forming unit-F in compar-ison with unseparated bone marrow mononuclear cells (Majumdar et al., 2000; Aslan et al., 2006; Kastrinaki et al., 2008) supporting our results attributing MSC characteristics to freshly isolated dermal CD73 þ cells, which are also CD105 þ . A comparison of the cell surface makers of adherent dermal-and bone marrow-derived MSCs revealed that these two cell types have very similar marker expression profiles (Ishii et al., 2005; Wagner et al., 2005) . CD271 and SSEA-4 expression might point toward a progenitor nature compared with terminally differentiated fibroblasts, particularly because both molecules have been previously reported as promising markers for the isolation of MSCs from bone marrow (Jarocha et al., 2008) .
We found that isolated CD271 þ and SSEA-4 þ dermal adherent cells were significantly more prone to undergo Merge SSEA-4 -Total Figure 5 . Dermal CD271 þ and SSEA-4 þ cells differ in osteogenic and chondrogenic capacity. (a) Osteogenic differentiation of CD271 þ , CD271 À , and total adherent cells, or of SSEA-4 þ , SSEA-4 À , and total adherent cells (b) (2 Â 10 4 cells per well, duplicates, Alizarin red). (c, d) Osteogenic differentiation expressed in units of alkaline phosphatase (AP). Error bars indicate mean ± SD (donor age: 3-10 years, n ¼ 5). Significance: *Po0.05, tested by a paired t-test. Chondrogenesis assays of CD271 þ , CD271 À , and total adherent cells (e, arrow: chondrocytes), or of SSEA-4 þ , SSEA-4 À , and total adherent cells (f; toluidine blue, donor age: 2-12 years, n ¼ 3). (g) Adherent dermal cells analyzed by flow cytometry (1 Â 10 4 cells displayed, donor age: 3-9 years, n ¼ 4). Immunofluorescence of cultured dermal cells. Bar (a, b) ¼ 200 mm, (e-g) ¼ 50 mm. n.s., nonsignificant.
adipogenesis than their respective negative fractions. Moreover, a correlation between the percentage of CD271 þ and SSEA-4 þ cells and their differentiation capacity was identified. Interestingly, CD271 þ cells exhibited elevated osteogenic and chondrogenic differentiation potential as compared with the negative and total adherent cell fractions. SSEA-4 þ cells did not differ from the related cell fractions, indicating the existence of distinct subtypes of MSCs in human dermis. Only cells within the adherent CD271 þ dermal cell population fulfil the proposed criteria of multipotent MSCs (Dominici et al., 2006) with (i) adherence to plastic and (ii) differentiation potential in vitro into osteoblasts, adipocytes, and chondrocytes. The observation that CD271 þ cells exhibiting a stem cell character exist, apart from bone marrow, also in other tissues is corroborated by a report about MSCs derived from human synovium (Jones et al., 2008) . In line with our results, CD271 þ cells isolated from human synovium have a clearly elevated mesenchymal differentiation capacity. The anatomical niche for cutaneous MSCs is not entirely clear. The follicular connective sheath and the papilla have been considered to represent the site of dermal MSCs (Lako et al., 2002; Richardson et al., 2005; Hoogduijn et al., 2006; Kruse et al, 2006) . Less is known about the distribution of MSCs in hair follicle-free dermis. This study and others provide evidence for the occurrence of dermal stem cells in human foreskin independent of hair follicles (Toma et al., 2005; Chen et al., 2007; Lorenz et al., 2008) . It is conceivable that dermal MSCs are located in a perivascular pattern, which has been shown for a variety of organs (Crisan et al., 2008; Morikawa et al, 2009 ). Owing to their localization and their expression of CD146, these cells might be related to pericytes. CD146 is expressed on pericytes (Crisan et al., 2008) and all types of human endothelial cells (Bardin et al., 2001) . It may be speculated that also the dermal MSCs characterized in this study are of perivascular origin, because B20% of adherent dermal cells expressed CD146 while lacking endothelial markers CD31 and CD34 (not shown).
It is conceivable that because of their morphological similarity, dermal MSCs are present among already wellstudied fibroblast subsets. The functional heterogeneity of morphologically homogenous fibroblast cultures has already been described (Goldring et al., 1990; Sorrell et al., 2007) . Various studies suggest a role of fibroblasts in angiogenesis after injury and support of vascular endothelial cell differentiation and basement membrane formation (Sorrell et al., 2007 (Sorrell et al., , 2008 Salvolini et al., 2010) . The regenerative role of fibroblasts has also been shown in a comprehensive study using a skin reconstruction model (Aoki et al., 2004) . It remains to be determined whether these regenerative characteristics are carried by all fibroblasts, or whether they are reserved to different subsets of progenitor cells residing in human dermis.
Our study makes an attempt to phenotype, isolate, and differentiate subpopulations of cells in the human dermis expressing MSC markers, which to our knowledge is previously unreported. The results might also have an impact on our understanding of certain aspects in dermatopathology as dermal MSCs potentially have a role in the evolution of skin neoplasms (Sellheyer and Krahl, 2010) .
MATERIALS AND METHODS
Skin samples
Foreskin samples (donor age: 10 months-12 years) were obtained as discarded material from routine circumcisions according to the Declaration of Helsinki principles, and following approval by the local ethics committee and informed written consent by the parents.
Preparation and culture of dermal single-cell suspensions and bone marrow-derived MSCs
Skin samples were depleted of subcutaneous tissue and incubated on 1.2 U ml À1 Dispase II (Roche Applied Science, Penzberg, Germany) in phosphate-buffered saline (Gibco, Eugene, OR) overnight at 4 1C. The dermis was separated from the epidermis and digested in 0.71 U ml À1 Liberase Blendzyme 3 (Roche Applied Science) for 90 minutes at 37 1C in a shaking water bath. Cells were passed through a 40-mm cell strainer and either directly processed for flow cytometric analysis or magnetic-activated cell sorting or plated in 225-cm 2 tissue culture flasks (Nunc, Roskilde, Denmark) containing mesenchymal growth medium (a-MEM (Gibco) supplemented with 10% fetal calf serum (PromoCell, Heidelberg, Germany), 100 U ml À1 penicillin, and 100 mg ml À1 streptomycin (Gibco)). Nonadherent cells were removed by medium changes every 48 hours. Adherent cells were grown until they reached 80% confluence, trypsinized, and subjected to magnetic-activated cell sorting and/or flow cytometry.
Bone marrow-derived MSCs were prepared as described (Schallmoser et al., 2008) . For flow cytometry and differentiation experiments, cryopreserved cells were thawed, plated in tissue culture flasks containing mesenchymal growth medium, and grown to 80% confluence.
Magnetic-activated cell sorting
Freshly prepared dermal cells were labeled with phycoerythrin (PE)anti-CD73 (AD2; BD Biosciences, San Jose, CA) and PE-anti-CD90 (5E10; BD Biosciences), incubated with anti-PE-microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), and further processed according to the manufacturer's instructions. In another series of experiments, cultured cells were trypsinized, labeled with biotinylated anti-CD271 (BD Biosciences), or purified anti-SSEA-4 (MC813-70; Millipore, Billerica, MA) and biotinylated goat anti-mouse IgG (H þ L) (Caltag, Buckingham, UK), followed by incubation with antibiotin microbeads. (166707), PE-anti-SSEA-4 (MC813-70; R&D Systems, Minneapolis, MN), FITC-anti-CD31 (WM59), and PE-anti-STRO-1 (STRO-1; Serotec, Kidlington, UK). Appropriate isotype controls were included and gates were set according to isotype-matched controls. Dead cells were excluded with 7-amino-actinomycin-D (Calbiochem, Darmstadt, Germany). Analysis of cells was performed on a LSR-II (BD Biosciences) and data were evaluated using the FlowJo software (Tree Star, Ashland, OR).
Flow cytometry
In vitro differentiation assays
For adipogenic differentiation, cells (2 Â 10 4 cells per well) were seeded in 48-well plates in duplicates and cultured in mesenchymal growth medium. Upon reaching confluence, adipogenic induction medium (mesenchymal growth medium supplemented with 0.2 mM indomethacin, 0.1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 10 mg ml À1 recombinant human insulin (all from Sigma-Aldrich, St Louis, MO)) was applied for 21 days. Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich) and stained with Oil red O (Sigma-Aldrich). The differentiated cells were counted and statistically analyzed.
For osteogenic differentiation, confluent cells (48-well plate, duplicates) were stimulated with osteogenic induction medium (mesenchymal growth medium supplemented with 0.1 mM dexamethasone, 50 mg ml À1 ascorbic acid and 10 mM glycerol 2-phosphate (all from Sigma-Aldrich)) for 21 days and then either stained with Alizarin red (Sigma-Aldrich) or subjected to an AP assay. For this, cells were lysed (CelLytic M; Sigma-Aldrich) and the supernatant was subjected to analysis by a fluorometric AP Detection Kit (Sigma-Aldrich) according to the manufacturer's instructions.
For chondrogenic differentiation, cells (2.5 Â 10 5 ) were placed in chondrogenic medium (D-MEM/F-12 medium containing 2 mM L-glutamine, 100 mg ml À1 sodium pyruvate, 0.1 mM nonessential amino acids (all from Gibco), 1% insulin transferrin sodium selenite plus, 50 mg ml À1 ascorbic acid 2-phosphate, 0.1 mM dexamethasone (all from Sigma-Aldrich), 10 ng ml À1 TGFb3 (R&D Systems)), centrifuged at 450g for 5 minutes, and pellets were cultivated for 21 days. Micromasses were fixed in 4% paraformaldehyde, embedded in O.C.T. (Tissue-Tek, Sakura Finetek, Zoeterwoude, The Netherlands), cut into 5 mm sections, stained with toluidine blue (Sigma-Aldrich), and analyzed.
Negative controls, in which media supplements inducing differentiation were omitted, were included for each differentiation assay and did not show spontaneous differentiation. Moreover, adipogenic and osteogenic differentiation of adherent dermal cells in contrast to negative controls was confirmed by molecular analysis of the expression of peroxisome proliferator-activated receptor-g-2 or AP and osteocalcin, respectively (Supplementary Figure S1 online).
Immunohistochemistry
Skin sections (4 mm) were fixed in ice-cold acetone for 10 minutes and air-dried. Purified primary antibodies (anti-CD73 (AD2), anti-CD90 (5E10), anti-CD271 (C40-1457) (all from BD Biosciences)), anti-CD105 (166707), anti-SSEA-4 (MC813-70; R&D Systems), and isotype controls were diluted in 2% BSA/phosphate-buffered saline, applied to the sections, and incubated overnight at 4 1C. Endogenous peroxidase was blocked by incubation with 0.03% hydrogen peroxide/methanol (room temperature, 10 minutes). Subsequently, sections were incubated with biotin-conjugated goat anti-mouse IgG (room temperature, 60 minutes) using the Elite mouse IgG Vectastain Kit (Vector Laboratories, Burlingame, CA). Biotinylated antibodies were detected with horseradish peroxidase-streptavidin and visualized with amino-ethyl-carbazole (Dako). Sections were counterstained with hematoxylin. Photomicrographs were taken using an Eclipse 80 microscope (Nikon, Tokyo, Japan).
Immunofluorescence
Freshly isolated dermal cells were cultured in eight-well-chamber slides (Lab-Tek; Nunc) for 5 days. Adherent cells were fixed with methanol and incubated with APC-anti-CD271 (C40-1457; BD Biosciences), PE-anti-SSEA-4 (MC813-70; R&D Systems), and isotype controls diluted in 2% BSA/phosphate-buffered saline overnight at 4 1C. Slides were mounted using Vectashield (Vector Laboratories) and images were recorded using a confocal laser scanning microscope (LSM 410; Carl Zeiss, Jena, Germany).
Statistical analysis
Differences between groups were assessed using the Mann-Whitney Utest or a paired t-test for related groups, respectively (GraphPad Software, La Jolla, CA). The reported P-value is a result of a two-sided test. A P-value below 5% was considered statistically significant.
